Literature DB >> 2875158

Saliva secretion of chloroquine in man.

F A Ogubona, A A Lawal, C O Onyeji.   

Abstract

The presence of chloroquine in saliva from seven healthy volunteers for 21 days after a single 600 mg oral dose of the drug was established by chromatographic and spectroscopic methods. The results showed the drug to be rapidly absorbed with a tmax in saliva of 3.9 +/- 1.6 h. A long elimination half-life of 7-20 days, calculated from the saliva concentration-time profile, is in agreement with values previously reported for the drug using plasma level data. In three of the volunteers from whom simultaneous blood samples were obtained, the mean Cs/Cp value was 1.20 +/- 0.27. It is suggested that saliva level determination may be used in evaluating patient compliance, therapeutic drug monitoring and pharmacokinetic parameters of chloroquine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875158     DOI: 10.1111/j.2042-7158.1986.tb04632.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

Review 2.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Influence of local radiotherapy on penetration of fluconazole into human saliva.

Authors:  J Oliary; M Tod; K Louchahi; O Petitjean; B Frachet; V Le Gros; N Brion
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

4.  Excretion of chloroquine and desethylchloroquine in human milk.

Authors:  F A Ogunbona; C O Onyeji; O O Bolaji; S E Torimiro
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.